The company had a net profit of Rs 44.61 crore for the same period in the previous fiscal, JB Chemicals & Pharmaceuticals said in a filing to the Bombay Stock Exchange (BSE).
As the company sold its Russia-CIS OTC business to Cilag GmbH International, a subsidiary of US-based Johnson and Johnson for Rs 754.53 crore, the results of the current quarter are not comparable with the same period previous fiscal.
2040
6000
17340
24779
1790
2166
1995
0
397
0
3898
4717
259
499
2991
5982
6942
11969
9600
12500
339
495
873
910
27181
0
910
0